Capital Fund Management (CFM)’s Inovio Pharmaceuticals INO Stock Holding History

Capital Fund Management (CFM)’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,812	Closed	-$380K	–	1526
2022 Q1	$380K	Buy	+8,812	New	+$397K	﹤0.01%	1352
2016 Q2	–	Sell	-1,925	Closed	-$201K	–	1638
2016 Q1	$201K	Buy	+1,925	New	+$149K	﹤0.01%	1441
2015 Q1	–	Sell	-3,975	Closed	-$438K	–	1582
2014 Q4	$438K	Buy	+3,975	New	+$486K	0.01%	1185

Other funds holding INO

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Capital Fund Management (CFM)'s INO Position: Q2 2022 in Review

Capital Fund Management (CFM) sold out of Inovio Pharmaceuticals (INO) in Q2 2022, closing a stake of 8,812 shares — an estimated $380K sold.

Capital Fund Management (CFM) first reported a position in INO in Q4 2014 and held it in 3 quarters. The position peaked at $438K in Q4 2014. 184 funds tracked by Wall St. Rank hold INO as of Q2 2022.

Capital Fund Management (CFM) reported no remaining Inovio Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Capital Fund Management (CFM) sold 8,812 Inovio Pharmaceuticals shares in Q2 2022, an estimated $380K.
Capital Fund Management (CFM) first reported a position in Inovio Pharmaceuticals in Q4 2014 and held it in 3 quarters.
Capital Fund Management (CFM)'s Inovio Pharmaceuticals position peaked at $438K in Q4 2014.
184 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2022, filed 12 Aug 2022.